A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MD / muscular dystrophy

[Related PubMed/MEDLINE]
Total Number of Papers: 213
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MD  (>> Co-occurring Abbreviation)
Long Form:   muscular dystrophy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients With Muscular Dystrophy in a Multidisciplinary Care Setting. ---
2020 Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models. DCM, TRPV2
2019 A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies-In Vitro and In Vivo Treatments to Boost Cellular Engraftment. ---
2019 AAV-based gene therapies for the muscular dystrophies. AAV
2019 Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human induced pluripotent stem cells. DMD, hiPSC-CMs
2019 Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B. Ang II, BP, TGF-beta
2019 Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy. TPr
2019 Changes in perceived social support predict changes in depressive symptoms in adults with physical disability. MS, MSPSS, SCI
2019 Dysphagia diagnosis with questionnaire, tongue strength measurement, and FEES in patients with childhood-onset muscular dystrophy. EAT-10, FEES, MITP
10  2019 Frequency of reported pain in adult males with muscular dystrophy. CTRL, LGMD, VAS
11  2019 Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle. ECM
12  2019 Heart Transplantation Ameliorates Ambulation Capacity in Patients With Muscular Dystrophy - An Analysis of 9 Cases. ---
13  2019 Molecular Genetics Analysis of 70 Chinese Families With Muscular Dystrophy Using Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing. ACMG, MLPA, NGS
14  2019 Quality of life in adults with muscular dystrophy. ADL, BMD, DMD, KEMVC, LGMD
15  2019 Relationship Between Fear of Falling and Physical Activity in People Aging With a Disability. MS, PPS, SCI
16  2019 Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance. CMR, FSHD1, LGE
17  2019 The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies. CMR
18  2019 The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries. NGO, SMA
19  2019 Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice. PS
20  2019 Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions. FSHD
21  2018 A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice. Syt-7, WT
22  2018 ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies. ACEIs
23  2018 Chick embryonic cells as a source for generating in vitro model of muscle cell dystrophy. ---
24  2018 Electrocardiographic and echocardiographic findings in muscular dystrophy patients with heart failure. HF, LV
25  2018 Factors affecting the health-related quality of life of caregivers of patients with muscular dystrophy. HRQoL
26  2018 Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach. CK, CMR, EDVI, ESVI, LGE, LV, miRNAs
27  2018 Muscular Dystrophy Model. DMD
28  2018 Oligomerization of Prph2 and Rom1 is essential for photoreceptor outer segment formation. OSs, RP, WT
29  2018 Partnership between families of children with muscular dystrophy and healthcare professionals: From parents' perspective. ---
30  2018 Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy. ACSA, CTRL, GM, LBM, MVC, PA
31  2018 The cardiorespiratory response and physiological determinants of the assisted 6-minute handbike cycle test in adult males with muscular dystrophy. A6MCT, BMD, DMD, FEV1, FSHD, FVC, HGS, HR, LGMD, VE
32  2018 Urinary N-terminal fragment of titin is a marker to diagnose muscular dystrophy in patients with cardiomyopathy. AUC, DCM, HCM, U-TN
33  2018 [Molecular therapies in muscular dystrophies]. ---
34  2017 Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Developed in a Patient with Progressive Muscular Dystrophy: A Case Report and Review of the Literature. ALT/WDLS
35  2017 Burden of neurological conditions in Canada. AD, ALS, BT, CP, HD, MS, NPHSNC, PD, SB, TS
36  2017 Capture-recapture methodology to study rare conditions using surveillance data for fragile X syndrome and muscular dystrophy. FXS
37  2017 Long-term non-invasive ventilation in muscular dystrophy. NIV
38  2017 Solace in solidarity: Disability friendship networks buffer well-being. MS, PPS, SCI
39  2017 Targeted massively parallel sequencing and histological assessment of skeletal muscles for the molecular diagnosis of inherited muscle disorders. ---
40  2017 The muscular dystrophic chicken is hypernatremic. alpha ENaC, AQP, WL
41  2017 Using Administrative Data to Ascertain True Cases of Muscular Dystrophy: Rare Disease Surveillance. DBMD
42  2016 Bone health measured using quantitative ultrasonography in adult males with muscular dystrophy. CTRL, DR, FSH, LG, MST, TAACSA
43  2016 Cardiac Disease Burden and Risk of Mortality in Hospitalized Muscular Dystrophy Patients. HF, VT
44  2016 Cavin4b/Murcb Is Required for Skeletal Muscle Development and Function in Zebrafish. ---
45  2016 Characterization of WWP1 protein expression in skeletal muscle of muscular dystrophy chickens. ---
46  2016 Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies. miRNA
47  2016 Clinical applications of next-generation sequencing-based gene panel in patients with muscular dystrophy: Korean experience. CK, LGMD
48  2016 Comparative transcriptome analysis of muscular dystrophy models Large(myd), Dmd(mdx)/Large(myd) and Dmd(mdx): what makes them different? DEGs, eMyHC, myd
49  2016 Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies. G-CSF
50  2016 Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice. DGC
51  2016 Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups. MS, PPS, SCI, UW-SES
52  2016 Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation. ---
53  2015 A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology. FHL1
54  2015 Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models. ---
55  2015 Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy. JIIM
56  2015 Cyclooxygenase-2 or tumor necrosis factor-alpha inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle. CAM, CCTF, COX2, MSC, pFUS, TNF-alpha
57  2015 Development of a tool to describe overall health, social independence and activity limitation of adolescents and young adults with disability. FXS, QOL, SB
58  2015 Early myocardial damage assessment in dystrophinopathies using (99)Tc(m)-MIBI gated myocardial perfusion imaging. BMD, DMD, GMPI
59  2015 Falls among adults aging with disability. MS, PPS, SCI
60  2015 Fibronectin-based scaffold domain proteins that bind myostatin: a patent evaluation of WO2014043344. ---
61  2015 Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy. ---
62  2015 Hospitalizations and emergency room visits for adolescents and young adults with muscular dystrophy living in South Carolina. ER, IP
63  2015 Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario. ADRD, LTC, RAI
64  2015 Model organisms in the fight against muscular dystrophy: lessons from drosophila and Zebrafish. DMD
65  2015 Muscular dystrophy-related hospitalizations among male pediatric patients in the United States. DMD
66  2015 Phenotype-Genotype Analysis of Chinese Patients with Early-Onset LMNA-Related Muscular Dystrophy. EDMD, HEK293, L-CMD, LMNA
67  2015 Report of a patient with limb-girdle muscular dystrophy, ptosis and ophthalmoparesis caused by plectinopathy. LGMD2Q, WES
68  2015 Serum Enzyme Profiles Differentiate Five Types of Muscular Dystrophy. ---
69  2015 Zebrafish needle EMG: a new tool for high-throughput drug screens. dpf, EMG
70  2014 "I have got something positive out of this situation": psychological benefits of caregiving in relatives of young people with muscular dystrophy. ---
71  2014 Aging with a disability and state vocational rehabilitation services. LEP, MS, SCI, VR
72  2014 Cancer risk among patients with hereditary muscular dystrophies: a population-based study in Taiwan, 1997-2009. CI, SIRs
73  2014 Disparities in health care utilization by race among teenagers and young adults with muscular dystrophy. ---
74  2014 Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies. MAO, ROS
75  2014 Myofiber-specific inhibition of TGFbeta signaling protects skeletal muscle from injury and dystrophic disease in mice. MT, TGF
76  2014 Posterior restoration of left ventricle and mitral valve repair in patients with muscular dystrophy. CHF, LV, MR, NYHA
77  2014 Risk of fracture in patients with muscular dystrophies. aHR, CI, MDs
78  2014 Sarcopenia and sarcopenic obesity in patients with muscular dystrophy. ALMI, DXA, HHD
79  2014 Social support, depression, and physical disability: age and diagnostic group effects. MS, SCI
80  2014 Use of an electronic medical record to create the marshfield clinic twin/multiple birth cohort. EMR, GWAS, MCTC
81  2014 Use of state administrative data sources to study adolescents and young adults with rare conditions. FXS, SB
82  2013 Acceptance of pain in neurological disorders: associations with functioning and psychosocial well-being. MS, PPS, SCI
83  2013 Clinical anatomy of vertebrae in scoliosis: global analysis in four different diseases by multiplanar reconstructive computed tomography. AIS, CG, CL, CP, CT, PWI
84  2013 Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. AAV, ANP, DCM
85  2013 Rehabilitation of the muscular dystrophies. ---
86  2013 S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase. S1P, S1P2, SCs, STAT3
87  2013 Self-reported depression and physical activity in adults with mobility impairments. GLTEQ, IPAQ, MS, PHQ-9, PPS, SCI
88  2012 Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury. BMI, MS, PPS, SCI, WC
89  2012 Community-based study of health-related quality of life in spinal cord injury, muscular dystrophy, multiple sclerosis, and cerebral palsy. CP, HRQoL, MS, SCI
90  2012 Computational Analysis of Muscular Dystrophy Sub-types Using A Novel Integrative Scheme. APC, MSVMs, PPI
91  2012 Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. TGF-beta
92  2012 Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma. RMS
93  2012 Effects of pain and fatigue on physical functioning and depression in persons with muscular dystrophy. ---
94  2012 Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. S1P, S1PR2, SCs, SPL, STAT3
95  2012 Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin. N-ABD
96  2011 14.1 T whole body MRI for detection of mesoangioblast stem cells in a murine model of Duchenne muscular dystrophy. ---
97  2011 Assessment of spatio-temporal gait parameters using inertial measurement units in neurological populations. MND, PD, TDA
98  2011 Central mechanisms during fatiguing muscle exercise in muscular dystrophy and fibromyalgia syndrome: a study with transcranial magnetic stimulation. FMS, ICI, TMS
99  2011 Combined effects of muscular dystrophy, ecological stress, and selenium on blood antioxidant status in broiler chickens. MDA
100  2011 Fatigue and aging with a disability. MS, PPS, PROMIS, SCI